JAMES HARROW: Open Payments
NPI 1104992411 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 26 payments from 11 companies in 2025. Trend: 2023 $267 · 2024 $448 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $117 |
| Indivior Inc. | 3 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Corium, LLC | 4 | $62 |
| Tris Pharma Inc | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Ossur Americas, Inc. | 1 | $17 |
Products named: INGREZZA, SUBLOCADE, TRINTELLIX, Azstarys, Dyanavel XR, FANAPT, Qelbree, INSPIRE.
Industry payments across AL — which companies pay providers there.
